Actuate Therapeutics, Inc. (ACTU) Live Share Price, Invest From India

Actuate Therapeutics, Inc. Stock Performance

as on September 23, 2026 at 5:10 am IST

Day's Low
Day's High
$0.84
Day's Price Range
$0.93
$0.85
1.35%
Downside
9.22%
Upside
52 Week's Low
52 Week's High
$0.89
52-Week Price Range
$8.49
$0.85
-4.52%
Downside
897.06%
Upside

Actuate Therapeutics, Inc. share price movements today

Previous Close: $0.91
Open: $0.93
Volume: 246.3K
Market Cap: $23.6M
Day's Low - High: $0.84 - $0.93
52 Week Low - High: $0.89 - $8.49

Actuate Therapeutics, Inc. Historical Returns

1 Month Return: -28.56 %
3 Month Return: -54.86 %
1 Year Return: -87.2 %
3 Year Return: 0 %
5 Year Return: 0 %

Actuate Therapeutics, Inc. Stock Fundamentals & Key Indicators

Check Actuate Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$23.6M

EPS (TTM)

-0.89

Dividend Yield

0.00%

PE Ratio (TTM)

-1.1

Industry PE ratio

-2.33

PEG Ratio

-0.014497391681494028

Return On Equity TTM

-346.18%

Actuate Therapeutics, Inc. Stock Valuation

Track how Actuate Therapeutics, Inc. P/E has moved over time to understand its valuation trends.

Actuate Therapeutics, Inc. in the last 4 years

Overview
Trends

Lowest (-6.42x)

December 31, 2022

Today (-5.77x)

December 31, 2025

Industry (-2.33x)

December 31, 2025

Highest (-2.44x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: -5.77x

Actuate Therapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Actuate Therapeutics, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Actuate Therapeutics, Inc.	Buy	$23.6M	NA	-1.1	0.00%	0.00%
Moderna	Neutral	$61.5B	-60.76%	-19.3	-12.57%	0.00%
Vertex Pharmaceuticals	StrongBuy	$128.8B	177.16%	29.35	86.04%	0.00%
Regeneron	Buy	$80.8B	23.35%	18.48	84.86%	0.47%

Stock Returns calculator for Actuate Therapeutics, Inc. Stock including INR - Dollar returns

The Actuate Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Actuate Therapeutics, Inc. investment value today

Current value as on today

₹13,000

Returns

-₹87,000

(-87%)

Returns from Actuate Therapeutics, Inc. Stock

-₹87,990 (-87.99%)

Dollar Impact

₹990 (+0.99%)

Analyst Recommendation on Actuate Therapeutics, Inc. Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Actuate Therapeutics, Inc.. Average target price of $10.5

Indian Investors' Interest in Actuate Therapeutics, Inc. Stock

Search interest for Actuate Therapeutics, Inc. Stock has increased by 67% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 23, 2026 to September 22, 2026

Change:67% versus previous 30 day period

Actuate Therapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-
Operating Income	-7	-5	-5	-6	-6	-5	-5	-4	-5	-4
EBITDA	-8	-6	-5	-6	-6	-5	-5	-4	-5	-4
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	-	-	-	0	-	-	-	-	-	-
Income Before Tax	-8	-6	-5	-6	-6	-5	-5	-4	-5	-4
Income Tax Expense	-	-	-	-	-	-	-	0	-	-
Net Income	-8	-6	-5	-6	-6	-5	-5	-4	-5	-4
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Actuate Therapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-
Gross Profit	-	-	-	-
Operating Income	-20	-24	-25	-22
EBITDA	-20	-24	-25	-22
Interest Expense	0	0	0	0
Depreciation	0	0	2	-
Income Before Tax	-20	-24	-27	-22
Income Tax Expense	-	-	0	-
Net Income	-20	-24	-27	-22
Net Profit Margin	0.00%	0.00%	0.00%	0.00%

Actuate Therapeutics, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-8	-6	-5	-6	-6	-5	-5	-4	-5	-4
Operating Cash Flow	-5	-2	-9	-4	-4	-4	-6	-3	-5	-4
Investing Cash Flow	-	-	-	-	-	-	-	-	-	-
Financing Cash Flow	4	0	22	0	0	6	17	0	0	0
Change in Cash	0	-1	13	-4	-4	2	10	-3	-5	-3

Actuate Therapeutics, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-20	-24	-27	-22
Operating Cash Flow	-17	-21	-21	-19
Investing Cash Flow	-	-	-	-
Financing Cash Flow	19	4	27	23
Change in Cash	1	-17	5	4

Mutual Funds that own Actuate Therapeutics, Inc. Stock

Check out the Mutual Funds with significant holdings in Actuate Therapeutics, Inc..

Funds	Holdings	Shares Held
VANGUARD INDEX FUNDS	1.639821%	393790
Fidelity Salem Street Trust	0.414508%	99541
Fidelity Concord Street Trust	0.365096%	87675
VANGUARD SCOTTSDALE FUNDS	0.229597%	55136
Bridgeway Funds, Inc.	0.129015%	30982

See all

Global Institutional Holdings in Actuate Therapeutics, Inc.

Funds	Holdings
Vanguard	1.64%
iShares	0.16%
Bridgeway	0.1%

Insights on Actuate Therapeutics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 551.1% return, outperforming this stock by 638.3%
NEGATIVE IMPACT
Price Dip
In the last 7 days, ACTU stock has moved down by -7.8%

About Actuate Therapeutics, Inc.

Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating treatments for various cancers. Its primary drug candidate is Elraglusib Injection, an innovative glycogen synthase kinase-3 (GSK-3) inhibitor designed to combat metastatic pancreatic ductal adenocarcinoma. Furthermore, Elraglusib is being developed to address other malignancies, including Ewing sarcoma, metastatic melanoma, and colorectal cancer. Originally named Apotheca Therapeutics, Inc., the organization rebranded as Actuate Therapeutics, Inc. in October 2015. Established in 2015, the company maintains its headquarters in Fort Worth, Texas.

Organisation	Actuate Therapeutics, Inc.
Headquarters	1751 River Run, Fort Worth, TX, 76107, US
Industry	Biotechnology
CEO	Daniel Schmitt
E-voting on shares	Click here to vote

Key Management of Actuate Therapeutics, Inc.

Name	Title
Mr. Daniel M. Schmitt	CEO, President & Director
Dr. Andrew P. Mazar Ph.D.	Co-Founder & COO
Mr. Paul J. Lytle CPA	Chief Financial Officer
Dr. Alan Kozikowski Ph.D.	Scientific Founder and Advisor

FAQs

What is Actuate Therapeutics, Inc. share price today?

Actuate Therapeutics, Inc. share price today is $0.85 as on September 22, 2026 at 11:40 pm IST. Actuate Therapeutics, Inc. share today touched a day high of $0.93 and a low of $0.84.

What is the 52 week high and 52 week low for Actuate Therapeutics, Inc. share?

Actuate Therapeutics, Inc. share touched a 52 week high of $8.49 on October 10, 2025 and a 52 week low of $0.89 on September 21, 2026. Actuate Therapeutics, Inc. stock price today i.e. September 22, 2026 at 11:40 pm IST is trending at $0.85,which is 89.97% down from its 52 week high and -4.33% up from its 52 week low.

What is Actuate Therapeutics, Inc.'s market capitalisation today?

Actuate Therapeutics, Inc. market capitalisation is $0.00T as on September 22, 2026 at 11:40 pm IST.

How to invest in Actuate Therapeutics, Inc. Stock (ACTU) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Actuate Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Actuate Therapeutics, Inc. Shares that will get you 1.7616 shares as per Actuate Therapeutics, Inc. share price of $0.85 per share as on September 22, 2026 at 11:40 pm IST.

What is the minimum amount required to buy Actuate Therapeutics, Inc. Stock (ACTU) from India?

Indian investors can start investing in Actuate Therapeutics, Inc. (ACTU) shares with as little as ₹95.58 or $1 (as of September 22, 2026 at 11:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹955.80 in Actuate Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on September 22, 2026 at 11:41 pm IST). Based on Actuate Therapeutics, Inc. share’s latest price of $0.85 as on September 22, 2026 at 11:40 pm IST, you will get 11.7440 shares of Actuate Therapeutics, Inc.. Learn more about fractional shares .